Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
267
NCT02250105
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2014
Completion: Jun 30, 2016
NCT02532218
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Start: Aug 31, 2015
Completion: Dec 31, 2016
NCT02574325
A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis
Start: Oct 31, 2015